BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 14
  • This Article
Peer-Review Report of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence-Based Medicine
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2014; 20(14): 4085-4092
Published online Apr 14, 2014. doi: 10.3748/wjg.v20.i14.4085
Table 5 Analyses of the sensitivity of tumor markers in different stages of gallbladder cancer n (%)
Clinical stagesCases (n)CEACA199CA242CA125
II71 (14.2)3 (42.8)a4 (57.1)ac2 (28.5)a
IIIA101 (10)5 (50)6 (60)3 (30)
IIIB332 (6)18 (54.5)20 (60.6)14 (42.4)
IVA62 (33.3)4 (66.6)4 (66.6)3 (50)
IVB223 (13.6)16 (72.7)16 (72.7)13 (59)
aP < 0.05 vs sensitivity of stage IVA, B;
cP < 0.05 vs sensitivity of CA125 and CA199. CA: Cancer antigen; CEA: Carcinoembryonic antigen.
Full Size Table
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.